$THLD:..$3.21.. Threshold Pharma announced that the FDA granted Fast Track designation for TH-302, an investigational anticancer drug for the treatment of previously untreated patients with metastatic or locally advanced unresectable soft tissue sarcoma
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.